CompletedNot Applicable

Refractory Status Epilepticus Treatment: Quality and Efficacy of Coma Induction

Switzerland147 participantsStarted 2020-04-22

Plain-language summary

This study is to investigate the effects of different treatment characteristics regarding the use of intravenous anesthetic drugs (IVADs) as a rescue treatment for refractory Status epilepticus (RSE) on course and outcome. A retrospective data extraction from the digital medical records, the electroencephalographic and microbiologic database of all consecutive adult patients with Status epilepticus (SE) admitted to the University Hospital Basel is undertaken.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosed SE between 2005 and 2019 who have been treated at intensive care units (ICUs) of the University Hospital of Basel Exclusion Criteria: * Patients with repetitive epileptic seizures not qualifying for SE or RSE * Patients with documented refusal of the general in-house consent

What they're measuring

number of in- hospital death

Timeframe: at baseline (T0)

Trial details

NCT IDNCT04333082

SponsorUniversity Hospital, Basel, Switzerland

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2021-08-15

View on ClinicalTrials.gov More Status Epilepticus trials